Sanofi (SNY)
NASDAQ: SNY · Real-Time Price · USD
44.55
-0.45 (-1.00%)
At close: Mar 6, 2026, 4:00 PM EST
44.55
0.00 (0.00%)
After-hours: Mar 6, 2026, 4:04 PM EST
Sanofi Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Sanofi stock have an average target of 61.5, with a low estimate of 58 and a high estimate of 65. The average target predicts an increase of 38.05% from the current stock price of 44.55.
Analyst Consensus: Buy
* Price targets were last updated on Sep 8, 2025.
Analyst Ratings
The average analyst rating for Sanofi stock from 6 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Sep '25 | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 2 | 2 | 2 | 1 | 1 | 1 |
| Hold | 1 | 1 | 1 | 3 | 4 | 4 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 5 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| UBS | UBS | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Jan 16, 2026 |
| Guggenheim | Guggenheim | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Dec 9, 2025 |
| JP Morgan | JP Morgan | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Dec 8, 2025 |
| Morgan Stanley | Morgan Stanley | Hold → Buy Upgrades $56 → $58 | Hold → Buy | Upgrades | $56 → $58 | +30.19% | Sep 8, 2025 |
| Deutsche Bank | Deutsche Bank | Hold → Strong Buy Upgrades n/a | Hold → Strong Buy | Upgrades | n/a | n/a | Sep 2, 2025 |
Financial Forecast
Revenue This Year
48.12B
from 46.72B
Increased by 3.01%
Revenue Next Year
50.92B
from 48.12B
Increased by 5.80%
EPS This Year
8.48
from 6.37
Increased by 32.99%
EPS Next Year
8.94
from 8.48
Increased by 5.50%
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 54.5B | 56.7B | |||
| Avg | 48.1B | 50.9B | |||
| Low | 44.9B | 47.1B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 16.8% | 17.9% | |||
| Avg | 3.0% | 5.8% | |||
| Low | -3.9% | -2.2% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 10.40 | 10.40 | |||
| Avg | 8.48 | 8.94 | |||
| Low | 5.88 | 6.37 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 63.1% | 22.6% | |||
| Avg | 33.0% | 5.5% | |||
| Low | -7.8% | -24.9% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.